|
We were the first IVF
clinic in the greater Seattle area to offer this exciting
new service. It is offered to couples at high risk
of producing genetically abnormal infants, and older
IVF patients whose eggs, and hence embryos, may be
genetically abnormal, leading to
the failure of implantation or
early miscarriage, i.e. repeated IVF
failure. The biopsy identifies genetically abnormal
embryos in couples that are both carriers of deleterious
recessive genetic disorders or in cases where one
partner is affected by a serious genetic disease.
PGD is the only reliable method for
family balancing / gender selection.
Background
Meiosis is the cell division that occurs in the gonads (ovaries or testicles) resulting in the formation of gametes that have only 23 chromosomes (half the 46 present in other normal human cells). This reduction division of cells is necessary to preserve the normal cellular chromosome count (46) after fusion of both the female and male gametes at fertilization .
Meiosis is a cellular division that occurs in two stages. Events during the first meiotic division include pairing and duplication of the 23 pairs of chromosomes with the extrusion of the first polar body of half the genetic material allowing the secondary oocyte to have only 23 chromosomes.
After fertilization, there is further replication of only the cells and not the chromosomes, with extrusion of further genetic material (second polar body) in order to maintain the chromosome count at 23 in the resulting oocytes.
With the fertilization of the oocyte by a single sperm, replication of the cell begins, forms an embryo and eventually several blastomeres. Successful preimplantation genetic diagnosis (PGD) is performed in two ways:
- Biopsy of the first and second polar body provides valuable information about the genetic makeup of the oocytes (eggs).
- Biopsy of one cell of the resulting
embryo (Blastomere Biopsy) enables us to learn about
the genetic make up of the embryo and enables couples
to select only unaffected embryos for transfer at
the time of IVF.
This ensures that infants are born without the serious
genetic disorders that may affect one or both of
their parents. In IVF cycles where all the embryos
are affected, couples may make an informed choice
to forgo the embryo
transfer and begin another IVF cycle.
The implementation of this program requires a multidisciplinary approach, and we
recommend consultation with our genetic counselors and perinatologist, as the specific genetic abnormality of the couple must be known in order to discuss confirmation of an ongoing unaffected pregnancy by chorionic villus sampling (CVS) or amniocentesis.
Preimplantation Genetic Diagnosis- What is Available?
Aneuploidy Testing
Aneuploidy testing enables embryos
to be checked for extra chromosomes that may have
serious consequences in life, or may be incompatible
with life. These include sex chromosome disorders,
like Turners Syndrome and Kleinfelters Syndrome. Also
included are Trisomy 21 (Down’s Syndrome), Trisomy
20, 22, 8, 13, 14, 15, 16, 17, and 18.
Preimplantation genetic diagnosis allows for the accurate determination of sex and is used in family balancing.
Translocations
Polar body testing and or blastomere biopsy are also used to diagnose aneuploids (extra or missing chromosomes) in eggs or embryos.
A specialized laboratory technique known as fluorescent in situ hybridization (FISH) can prevent the initiation of abnormal pregnancies, which may result in non-implantation or miscarriage and increase the stress and disappointment of repeated IVF failures.
Since many IVF
failures in women over 35 years of age are thought
to result from chromosomal abnormalities, the ability
to select chromosomally normal embryos for transfer
affords an excellent opportunity to improve success
rates.
Preimplantation genetic diagnosis (PGD) for Single Gene Defects
This technique enables us to test an embryo without damaging it by first removing one cell (blastomere) using a technique known as embryo biopsy. The gene of interest is copied many times using the polymerase chain reaction (PCR) and then genetic probes are used to explore the genetic makeup of the embryo.
One common technique is to genetically sex the embryo, as certain genetic disorders such as hemophilia A and muscular dystrophy are X linked.
Single Gene Defects
Other genetic deficiencies that are amenable to testing by PGD include:
-
Cystic Fibrosis
-
Tay Sachs Disease
-
Hemophilia A
-
Retinitis Pigmentosa
-
Sickle Cell Disease
-
Gaucher's Disease
-
Alport Disease
-
Alpha-1 -Antitrypsin
-
Fragile-X
-
Fanconi Anemia
|
|
Please call or make an appointment
with Dr. Kustin to learn
if PGD is a viable option for you.
|